🔎 Trials Near Me

Akèy › Kansè ovè › Illinois › Evanston

Etid klinik pou Kansè ovè nan Evanston, IL

7 etid pou Kansè ovè ap chèche patisipan nan sit nan ak bò kote Evanston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Ap rekriteFaz 2
  • NorthShore University HealthSystem-Evanston Hospital, Evanston
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi lwen
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi lwen
  • ak 2 plis
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT05564377

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Ap rekriteFaz 3
  • Northshore University Health System-Evanston Hospital, Evanston
Laj 18 ak plis · Fanm · Mizajou Sep 15, 2026 · NCT07214779

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ap rekrite
  • NorthShore University HealthSystem-Evanston Hospital, Evanston
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi lwen
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi lwen
  • ak 1 plis
Laj 35 a 50 · Fanm · Mizajou Aug 7, 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Ap rekriteFaz 1/2
  • Orchard Healthcare Research Inc, Skokie · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Ap rekriteFaz 3
  • Endeavor Health Evanston Kellogg Cancer Care Center, Evanston
Laj 18 ak plis · Fanm · Mizajou Jul 2, 2026 · NCT06819007

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Ap rekriteEtid obsèvasyon
  • Northshore University Health System, Evanston
Laj 18 ak plis · Tout sèks · Mizajou Feb 23, 2026 · NCT05974150

Etid Kansè ovè nan lòt vil

Lòt etid nan Evanston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.